Lawmaker Needles FDA Over Avandia Vote Details
A U.S. senator is asking the U.S. Food and Drug Administration to respond to accounts that an internal drug safety oversight board voted earlier in October to keep GlaxoSmithKline's diabetes drug...To view the full article, register now.
Already a subscriber? Click here to view full article